StockData
Psyence Biomedical Ltd. logo

Psyence Biomedical Ltd. (PBM) stock

PBMNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBMWW
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 22, 2026Score 0/30
$4.12−0.10 (-2.37%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Psyence Biomedical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2026 it was -$8.14M.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$8.14M–
FY2025Mar 31, 2025-$3.74M–
FY2024Mar 31, 2024-$2.95M–

More Psyence Biomedical figures

See a number that looks wrong?